Table 1.
Clinical variables that were tested in subjects with C-peptide production on random serum samples. Data are presented as means (standard deviation).
| Positive C-Peptide |
Negative C-Peptide |
||
|---|---|---|---|
| Number of Subjects | 38 | 103 | |
| Gender (Female) | 24 | 59 | p=0.57 |
| Body Mass Index | 25.0 (3.78) | 24.5 (3.35) | p=0.41 |
| Age of diabetes onset | 16.7 (10.6) | 16.7 (9.90) | p=0.98 |
| Diabetes duration in years | 19.2 (11.8) | 26.2 (13.1) | p=0.0045 |
| Hemoglobin A1c | 8.19% (2.27) | 7.95 (1.42) | p=0.45 |
| Positive anti-GAD antibody | 61.9% | 63.9% | p=1.00 |
| LDL Cholesterol | 111 (31.6) | 112 (28.3) | p=0.89 |
| HDL Cholesterol | 66.0 (21.1) | 63.5 (17.0) | p=0.51 |
| Triglycerides | 93.4 (56.8) | 81.5 (51.9) | p=0.29 |
| Current insulin pump use | 39.5% | 37.9% | p=0.85 |
| DKA Episodes (lifetime) | 3.59 (6.79) | 3.72 (11.4) | p=0.95 |
| Blood glucose for symptoms of hypoglycemia | 54.7 (17.4) | 51.9 (15.9) | p=0.41 |
| Nephropathy | 50.0% | 40.2% | p=0.34 |
| Neuropathy | 42.1% | 35.3% | p=0.56 |
| Retinopathy | 57.9% | 57.8% | p=1.00 |